<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>The prostate gland is highly susceptible to oncogenic transformation, many times more than other sex tissues, such as seminal vesicles. In fact, prostate cancer (PCa) will be diagnosed in one in seven lifetime patients, making PCa the subject of intense research aimed at clarifying its biology and providing adequate treatment. PCa is the fourth most common cancer in the world in terms of the overall population and the second most common cancer for the male population. It is postulated that the development of PCa may be influenced by dietary factors, physical and sexual activity, androgens, obesity, and inflammation, but their role in the development of prostate cancer still remains unclear. Extracellular matrix metalloproteinases (MMPs) and tissue metalloproteinase inhibitors (TIMPs) play an important role in many physiological and pathological processes, including proliferation, migration, invasion, cell differentiation, participation in inflammatory processes and angiogenesis. Numerous studies point to a direct relationship between MMPs and both local tumor invasion and the formation of distant metastases. High activity of MMPs is observed in solid tumors of various origins, which positively correlates with a poor overall survival rate. Although biochemical diagnostic markers of PCa are currently available, from the point of view of clinical practice, it seems particularly important to develop new and more sensitive markers allowing for early diagnosis and long-term monitoring of patients after PCa treatment, and the assessment of MMP activity in urine and serum of patients are potential factors that could play such a role.</p>
</abstract>

The prostate gland is highly susceptible to oncogenic transformation, many times more than other sex tissues, such as seminal vesicles. In fact, prostate cancer (PCa) will be diagnosed in one in seven lifetime patients, making PCa the subject of intense research aimed at clarifying its biology and providing adequate treatment. PCa is the fourth most common cancer in the world in terms of the overall population and the second most common cancer for the male population. It is postulated that the development of PCa may be influenced by dietary factors, physical and sexual activity, androgens, obesity, and inflammation, but their role in the development of prostate cancer still remains unclear. Extracellular matrix metalloproteinases (MMPs) and tissue metalloproteinase inhibitors (TIMPs) play an important role in many physiological and pathological processes, including proliferation, migration, invasion, cell differentiation, participation in inflammatory processes and angiogenesis. Numerous studies point to a direct relationship between MMPs and both local tumor invasion and the formation of distant metastases. High activity of MMPs is observed in solid tumors of various origins, which positively correlates with a poor overall survival rate. Although biochemical diagnostic markers of PCa are currently available, from the point of view of clinical practice, it seems particularly important to develop new and more sensitive markers allowing for early diagnosis and long-term monitoring of patients after PCa treatment, and the assessment of MMP activity in urine and serum of patients are potential factors that could play such a role.

The role of matrix metalloproteinases in pathogenesis, diagnostics, and treatment of human prostate cancer

Department of Urology and Urological Oncology

Department of Neonatology and Neonatal Intensive Care Unit

Postępy Higieny i Medycyny Doświadczalnej

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The prostate gland is highly susceptible to oncogenic transformation, many times more than other sex tissues, such as seminal vesicles. In fact, prostate...

The role of matrix metalloproteinases in pathogenesis, diagnostics, and treatment of human prostate cancer

Article Category: Review

Published Online: Mar 01, 2023

Page range: 9 - 20

Received: Feb 26, 2022

Accepted: Nov 15, 2022

DOI: https://doi.org/10.2478/ahem-2023-0002

Keywords
extracellular matrix, matrix metalloproteinases, prostatic neoplasms, prostate-specific antigen, prostatic hyperplasia

© 2023 Tomasz Wiśniowski et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The role of matrix metalloproteinases in pathogenesis, diagnostics, and treatment of human prostate cancer

Article Category: Review

Published Online: Mar 01, 2023

Page range: 9 - 20

Received: Feb 26, 2022

Accepted: Nov 15, 2022

DOI: https://doi.org/10.2478/ahem-2023-0002

Keywordsextracellular matrix, matrix metalloproteinases, prostatic neoplasms, prostate-specific antigen, prostatic hyperplasia

© 2023 Tomasz Wiśniowski et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Keywords
extracellular matrix, matrix metalloproteinases, prostatic neoplasms, prostate-specific antigen, prostatic hyperplasia